Aflivu 2 mg (Aflibercept SOLUTION) 2 MG

AFLIVU 2 MG is an intravitreal solution containing aflibercept, used for ophthalmic conditions. This medication is designed to target specific proteins in the eye to manage certain retinal disorders.

Strength

2 MG

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AFLIVU 2 MG is primarily used for the treatment of wet age-related macular degeneration (AMD) and other retinal conditions. It works by inhibiting vascular endothelial growth factor (VEGF), which can help reduce abnormal blood vessel growth in the retina. This medication is administered via intravitreal injection, directly into the eye, by a healthcare professional.

Side Effects

Common effects of AFLIVU 2 MG may include temporary vision disturbances, eye redness, or discomfort following the injection. Some patients may also experience floaters or increased intraocular pressure. These effects are generally mild and resolve on their own, but persistent or severe symptoms should be reported to a healthcare provider.

Precautions & Warnings

AFLIVU 2 MG should be used with caution in patients with a history of eye infections or inflammation. It is important to follow the healthcare provider's instructions for post-injection care to minimize the risk of infection. Patients should also inform their healthcare provider about any allergies or other medications they are taking before receiving this treatment.

Avoid Interactions

AFLIVU 2 MG may interact with other medications, particularly those that affect the immune system or blood clotting. Patients should avoid using this medication with other eye treatments unless directed by a healthcare provider. Alcohol and certain supplements may also influence the effectiveness or safety of this medication.

Frequently Asked Questions

AFLIVU 2 MG is used to treat wet age-related macular degeneration and other retinal conditions by inhibiting VEGF.

AFLIVU 2 MG is administered via intravitreal injection, directly into the eye, by a healthcare professional.

Common side effects may include temporary vision disturbances, eye redness, or discomfort following the injection.

Patients should avoid using AFLIVU 2 MG with other eye treatments unless directed by a healthcare provider.

Patients should inform their healthcare provider about any allergies or other medications they are taking before receiving this treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.